| Up
2005P-0402:
Amend or permit amendment of the labeling of all lithium-containing
drugs to include the additional indication "to reduce the incidence
of suicide and suicide attempts in manic-depressive illness."
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 09/28/2005
|
| 09/28/2005
|
| Individual Consumer
|
| Ross J.
Baldessarini, M.D. & Frederick K. Goodwin, M.D.
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
|
|
|
|
|
|
|
| Signature:
|
| William W. Vodra
|
|
|
| ACK1
|
| 09/28/2005
|
| 09/28/2005
|
| Federal Government
|
| HFA-305 to Arnold
& Porter
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Lyle D. Jaffe
|
|
|
|
|
|
| EC1
|
| 12/09/2005
|
| 11/22/2005
|
| Individual Consumer
|
| Mr. Dave Lowe
|
|
|
|
|
|
|
| html
|
|
|
|
|
|
|
| Signature:
|
| Lowe, Dave
|
|
|
|
|
|
| C1
|
| 01/30/2006
|
| 01/25/2006
|
| Consumer Group
|
| Suicide Awareness
Voices of Education (SAVE)
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Daniel J. Reidenberg, Psy.D.,
FAPA
|
|
|
| CR1
|
| 03/22/2006
|
| 03/21/2006
|
| Individual Consumer
|
| Ross J.
Baldessarini, M.D. & Frederick K. Goodwin, M.D.
|
|
|
|
|
|
|
| 5
|
|
|
|
|
|
|
|
|
|
|
| Signature:
|
| William W. Vodra
|
|
|
|
|
| LET1
|
| 03/27/2006
|
| 03/27/2006
|
| Federal Government
|
| HFD-005 to Arnold
& Porter LLP
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Jane A. Axelrad
|
|
|
|
| |
|
|
Top | Up
Page last updated
April 21, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
